MedTrace Logo

Pilot Study to Verify Effect of Smartpen Coordinated With Glucose Sensor.

NCT06310980 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2024-03-15

No results posted yet for this study

Summary

The Aim of this interventional study in to assess the effect of the use of a smartpen connected by an APP to continuous glucose sensors in a cohort of diabetic adolescents in not good metabolic control.

Primary endpoint: time in range Secondary endpoints: other glucometrics, Hba1c, treatment satisfaction.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

DEVICE

smartpen

use of a smartpen connected with glucose sensor by an digital application

Sponsors & Collaborators

  • Giulio Frontino

    lead OTHER

Principal Investigators

  • Riccardo Bonfanti, M.D. · IRCCS San Raffaele

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2024-07-01
Completion
2025-04-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06310980 on ClinicalTrials.gov